Research demonstrates anti-dengue virus effects in thrombocytopenic rats, enhancing platelet counts and reducing bleeding time.
This study investigated the anti - dengue hemorrhagic fever (DHF) and anti-dengue virus (DENV) properties of an extract containing six Vietnamese medicinal plants (HemoShield – HE ). HE in water (WE) and in 25 % ethanol (EE) exhibited anti-DENV activity against all four tested DENV serotypes (1, 2, 3, and 4), with the strongest effect observed with DENV2. Moreover, HE demonstrated apparent inhibitory activity against NS2B-NS3 pro enzyme responsible for viral replication with an IC 50 value of 48.5 ± 2.3 μg/mL. In the thrombocytopenia rats, HE -treated group showed a significant increase in platelet count (approximately 33.62 %; p < 0.05). Additionally, the bleeding time of 0.74 g/kg treatment group was significantly reduced by 33.4 % (p < 0.05). Antipyretic activity of HE in rabbits after 3-h treatment showed a significant reduction in body temperature (38.8 %; ΔT: 0.4 ± 0.1 °C) at a dose of 0.31 g/kg. Thus, our findings provided new in vitro and in vivo evidence demonstrating the effect of HE in alleviating DHF.
No takes yet. Share an insight, caveat, or question.
Bac et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: